Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5770044

CC(=O)c1ccc(N2CCN(C(=O)CCc3cnoc3-c3ccc(F)cc3)CC2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.49
GFER P55789 1/20 0.47
ALDH1A1 P00352 3/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 7/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 3/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 3/20 0.41
SLC6A7 Q99884 1/20 0.41
PARP1 P09874 1/20 0.41
PARP2 Q9UGN5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5777433 0.94 GFER (0.53) GFERALDH1A1HPGDHSD17B10MAPT
Trifluoroacetic Acid SCHEMBL5772610 0.90 GFER (0.53) GFERMAPTPOLBKMT2ALMNA
Trifluoroacetic Acid SCHEMBL5774077 0.90 POLB (0.51) GFERALDH1A1HPGDHSD17B10MAPT
Trifluoroacetic Acid SCHEMBL5771192 0.89 MEN1 (0.53) GFERALDH1A1MAPTKDM4EMAPK1
Trifluoroacetic Acid SCHEMBL5776834 0.85 HTT (0.46) GFERHPGDMAPTSMN1; SMN2POLB
Trifluoroacetic Acid SCHEMBL5777378 0.85 MAPT (0.50) GFERHPGDMAPTSMN1; SMN2POLB
Trifluoroacetic Acid SCHEMBL5776129 0.84 MEN1 (0.50) GFERALDH1A1MAPTKDM4ESMN1; SMN2
Trifluoroacetic Acid SCHEMBL5776847 0.84 MDM2 (0.39) GFERALDH1A1MAPTL3MBTL1KMT2A
Trifluoroacetic Acid SCHEMBL5775548 0.83 MAPT (0.53) RXFP1MAPTSMN1; SMN2L3MBTL1POLB
Trifluoroacetic Acid SCHEMBL5776691 0.83 GRM5 (0.48) GFERALDH1A1MAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR RXFP1 343/4885GFER 811/4885ALDH1A1 1045/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 RXFP1 281/4885GFER 1403/4885ALDH1A1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.